Some authors have found that SLNs, which were loaded with doxorubicin, were able to overcome P-glycoprotein (Pgp)-mediated multidrug resistance (MDR), both in vitro in resistant leukemia cells and in vivo in the murine leukemia mouse model [12,13]. The gene discussed is ABCB1; the disease is leukemia.